BTAI

Bioxcel Therapeutics, Inc.

$1.07-0.02 (-1.83%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

BioXcel Therapeutics, Inc. (BTAI) is a publicly traded company with 8 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 4 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.

Latest Insider Transactions

Showing 10 of 52 transactions (past 365 days)

BTAI
CEO
Exercise Conversion
$0
Mehta Vimal164 shares @ $0.00
Filed 2026-03-17Trade 2026-03-14
BTAI
CEO
Exercise Conversion
$0
Mehta Vimal219 shares @ $0.00
Filed 2026-03-17Trade 2026-03-15
BTAI
CFO
Exercise Conversion
$0
Steinhart Richard I33 shares @ $0.00
Filed 2026-03-17Trade 2026-03-14
BTAI
CFO
Exercise Conversion
$0
Steinhart Richard I35 shares @ $0.00
Filed 2026-03-17Trade 2026-03-15
BTAI
See Remarks
Exercise Conversion
$0
Rodriguez Javier33 shares @ $0.00
Filed 2026-03-17Trade 2026-03-14
BTAI
See Remarks
Exercise Conversion
$0
Rodriguez Javier35 shares @ $0.00
Filed 2026-03-17Trade 2026-03-15
BTAI
CSO
Exercise Conversion
$0
Yocca Frank33 shares @ $0.00
Filed 2026-03-17Trade 2026-03-14
BTAI
CSO
Exercise Conversion
$0
Yocca Frank35 shares @ $0.00
Filed 2026-03-17Trade 2026-03-15
BTAI
Director
Award
$0
Mack David J.17,000 shares @ $0.00
Filed 2026-01-12Trade 2026-01-09
BTAI
Director
Award
$0
Votruba Michal17,000 shares @ $0.00
Filed 2026-01-12Trade 2026-01-09

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →